Uncover key drivers, emerging technologies, and competitive movements shaping the gastric volvulus treatment market from 2026–2035 with trusted insights from The Business Research Company
What is the expected shift in the Gastric Volvulus Treatment Market’s size between 2026 and 2030?
The gastric volvulus treatment market size has experienced robust expansion in recent years. Projections indicate an increase in its valuation from $28.86 billion in 2025 to $30.8 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. Historically, this growth can be ascribed to several factors, including the availability of various surgical treatment options, the expansion of hospital emergency care services, enhanced diagnosis through imaging tests, the evolution of gastropexy procedures, and advancements in surgical expertise.
The gastric volvulus treatment market size is anticipated to undergo substantial growth in the upcoming years. It is forecast to grow to $39.4 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.3%. The expansion during this forecast period stems from factors such as the increase in minimally invasive surgery, enhanced emergency response systems, the uptake of advanced imaging, the proliferation of specialty surgical centers, and heightened clinical awareness. Key trends predicted for the forecast period encompass a rising inclination towards surgical intervention, an increased embrace of minimally invasive procedures, improved emergency diagnosis and management, the expansion of specialized surgical care, and a concentrated effort on rapid treatment to decrease mortality.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp
Which Drivers Are Shaping Strategic Decisions In The Gastric Volvulus Treatment Market?
The expanding elderly demographic is projected to boost the gastric volvulus treatment market in the future. This demographic consists of individuals aged 65 years and above, who frequently experience various health issues due to declining immunity and advancing age. Given that gastric volvulus primarily affects adults over 50 years old, an increase in this older population is consequently expected to stimulate market growth. For example, data released in January 2024 by the Population Reference Bureau (PRB), a US-based nonprofit organization, anticipates a rise in the number of Americans aged 65 and older from 58 million in 2022 to 82 million by 2050, representing a 47% increase, and their proportion of the overall population is predicted to grow from 17% to 23%. Thus, the rising geriatric population acts as a significant driver for the gastric volvulus treatment market.
What Segment Categories Are Covered In The Gastric Volvulus Treatment Market?
The gastric volvulus treatment market covered in this report is segmented –
1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus
2) By Treatment Type: Medication, Surgery
3) By Route Of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy
2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques
What Trends Are Projected To Support The Growth Of The Gastric Volvulus Treatment Market?
Major companies in the gastric volvulus treatment market are focusing on developing innovative solutions, such as next-generation oral immunomodulatory therapies, to address the growing demand for advanced treatment options that enhance long-term disease control and patient quality of life. These orally administered treatments target inflammatory and immune-driven mechanisms, presenting a more convenient and targeted alternative when compared with traditional systemic treatments that may carry higher side-effect risks and require more intensive management. For instance, in October 2023, Pfizer Inc., a US-based pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved VELSIPITY (etrasimod). VELSIPITY (etrasimod) is a once-daily oral sphingosine-1-phosphate (S1P) receptor activator for people with moderate to severe active ulcerative colitis (UC). VELSIPITY’s official suggested dosage is 2 mg. VELSIPITY enables adults with moderately to severely active UC to achieve steroid-free resolution with an oral, once-daily pill that has a positive benefit-risk profile. The FDA’s approval of VELSIPITY today signifies an important turning point for UC patients who need novel therapies for this long-term illness and are ready to begin advanced treatment.
Which Major Industry Participants Are Leading The Gastric Volvulus Treatment Market Growth?
Major companies operating in the gastric volvulus treatment market are Medtronic plc, Johnson & Johnson Services Inc., Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co KG, Cook Group Incorporated, B Braun Melsungen AG, ConMed Corporation, Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Ambu A S, Richard Wolf GmbH, USGI Medical, Ovesco Endoscopy AG, Endo Tools Therapeutics SA, ErgoSuture, Sutrue Ltd, Golden Stapler Surgical Co Ltd, TransEnterix Inc.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report
Which Region Is Projected To Lead The Gastric Volvulus Treatment Market During The Forecast Period?
North America was the largest region in the gastric volvulus market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Gastric Volvulus Treatment Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp
Browse Through More Reports Similar to the Global Gastric Volvulus Treatment Market 2026, By The Business Research Company
Gastric Ulcers Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report
Gastroparesis Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report
Gas Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/gas-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model